Cardiovascular safety of incretin-based therapy for type 2 diabetes: A meta-analysis of randomized trials

Int J Cardiol. 2017 Mar 1:230:324-326. doi: 10.1016/j.ijcard.2016.12.113. Epub 2016 Dec 26.

¹ Department of Medicine, University of Florida, Gainesville, FL, United States.
² Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, United States.
³ Department of Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, FL, United States.
⁴ Department of Medicine, Cleveland Clinic Foundation, Cleveland, OH, United States.
⁵ Department of Medicine, Jefferson University Hospital/Christiana Care Health System, Newark, DE, United States.
⁶ Department of Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, United States.
⁷ Department of Medicine, University of Florida, Gainesville, FL, United States. Electronic address: islam.elgendy@medicine.ufl.edu.

No abstract available

Keywords: Heart failure; Incretins; Meta-analysis; Mortality; Myocardial infarction; Stroke.

Publication types